These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4747426)

  • 1. [Clinical significance of the typological characteristics of the antibodies to deoxyribonucleic acid in children and adolescents with systemic lupus erythematosus].
    Belokrinitskiĭ DV; Prozorovaskaia NN; Levina SG
    Sov Med; 1973 Jun; 36(6):33-8. PubMed ID: 4747426
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of the passive haemagglutination reaction for determining antibodies against deoxyribonucleic acid (DNA).
    Levi MI; Poverenny AM
    J Hyg Epidemiol Microbiol Immunol; 1965; 9(4):465-77. PubMed ID: 5893708
    [No Abstract]   [Full Text] [Related]  

  • 3. [DNA antibodies, DNA and DNAase plasma activity in children suffering from systemic lupus erythematosus].
    Isaeva LA; Levina SG; Klimov VIu; Belokrinitskiĭ DV; Prozorovskaia NN
    Vopr Revm; 1973; 13(4):56-60. PubMed ID: 4589786
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical assessment of determining antibodies to deoxyribonucleic acid (DNA) with the aid of the passive hemagglutination test (PHA)].
    Nasonova VA; Poverennyĭ AM
    Ter Arkh; 1967 Sep; 39(9):38-44. PubMed ID: 5305103
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration of antibodies to deoxyribonucleic acid by counterelectrophoresis.
    Klajman A; Farkash R; Myers BD
    J Immunol; 1973 Oct; 111(4):1136-9. PubMed ID: 4728680
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of three assays for anti-DNA with three assays for the measurement of the role of complement in systemic lupus erythematosus in adolescents.
    Miller JJ; Hsu YP; Osborne CL; Kredich DW
    J Rheumatol; 1980; 7(5):660-4. PubMed ID: 7003143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological studies on DNA antibodies in lupus erythematosus (SLE, cDLE), with particular reference to photo-oxidized DNA (poDNA) antibody].
    Okuda M
    Arerugi; 1970 Apr; 19(4):260-6. PubMed ID: 5448917
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of determining antibodies to poly A: poly U in systemic lupus erythematosus].
    Nasonova VA; Alekberova ZS; Poverennyi AM; Podgorodnichenko VK
    Ter Arkh; 1972 Nov; 44(11):24-9. PubMed ID: 4666026
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systemic lupus erythematosus. Clinical, biological and immunological studies. (Report on 30 cases). II].
    Nouspikel P
    Praxis; 1968 Jun; 57(24):875-90. PubMed ID: 4888332
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical progression of apparent juvenile rheumatoid arthritis to systemic lupus erythematosus.
    Ragsdale CG; Petty RE; Cassidy JT; Sullivan DB
    J Rheumatol; 1980; 7(1):50-5. PubMed ID: 7354469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination and importance of antibodies against deoxyribonucleic acid in the systemic lupus erythematosus].
    Cebecauer L; Zitnan D; Rovenský J
    Bratisl Lek Listy; 1971 May; 55(5):546-55. PubMed ID: 4932194
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of anti-native DNA antibodies in systemic lupus erythematosus by the Crithidia luciliae method].
    Pigrau C; Martínez-Vázquez JM; Bacardi R; Pahissa A; Pastor M; Guardia J
    Med Clin (Barc); 1984 Jul; 83(6):227-31. PubMed ID: 6332255
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].
    Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A
    Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical importance of determining antibodies to DNA in systemic lupus erythematosus].
    Belokrinitskiĭ DV; Prozorovskaia NN; Savel'ev AI; Tareeva IE
    Vopr Revm; 1972; 12(1):8-16. PubMed ID: 5043579
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the titer of antibodies to DNA in patients with systemic lupus].
    Demin AA; Kolaev VA; Ananko AK
    Vopr Revm; 1966; 6(3):11-4. PubMed ID: 5995660
    [No Abstract]   [Full Text] [Related]  

  • 16. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
    Burdash NM; Teti G; Papadopoulos V
    Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies against native (double-strand) deoxyribonucleic acid and complement fixing antibodies in generalized lupus erythematosus with affected kidneys].
    Dostál C; Hána I; Bardfeld R; Stejskal J; Matl I; Zvárová J
    Vnitr Lek; 1984 May; 30(5):417-25. PubMed ID: 6331681
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 20. Deoxyribonucleic acid and its antibodies in systemic lupus erythematosus.
    Chee YC
    Singapore Med J; 1981 Dec; 22(6):323-31. PubMed ID: 7038879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.